Radical Prostatectomy More Complex With Obesity but Oncologic Outcomes Appear Similar
Obesity in itself is not a contraindication for radical prostatectomy, but it remains a risk factor for poor overall survival.
Related Articles
Program Guide – ASCO Meeting Program Guide
Alicia Morgans Dana-Farber Cancer Institute, Boston, MA Alicia Morgans, Kunhi Parambath Haresh, Mindaugas Jievaltas, David Olmos, Neal Shore, Egils Vjaters, Nianzeng Xing, Ateesha Mohamed, Natasha…
Program Guide – ASCO Meeting Program Guide
Chadi Hage Chehade Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT Chadi Hage Chehade, Yeonjung Jo, Zeynep Irem Ozay, Micah Ostrowski,…
Program Guide – ASCO Meeting Program Guide
Alicia Morgans Dana-Farber Cancer Institute, Boston, MA Alicia Morgans, Kunhi Parambath Haresh, Mindaugas Jievaltas, David Olmos, Neal Shore, Egils Vjaters, Nianzeng Xing, Ateesha Mohamed, Natasha…
Poor Sleep May Increase Death Risk in Patients on Hemodialysis
Patients receiving hemodialysis for kidney failure frequently experience sleep problems which may lower their survival.
EAU Guidelines on Renal Transplantation – THE GUIDELINE – Uroweb
The European Association of Urology (EAU) Renal Transplantation Guidelines aim to provide a comprehensive overview of the medical and technical aspects relating to renal transplantation.
Maria Uloko, MD, discusses the lack of resident training on female sexual dysfunction
“Patients are having a hard time getting diagnosed because physicians are leaving medical training and medical education without getting this solid curriculum around female sexual…
Clinical-genomic Characterization Unveils More Aggressive Disease Features in Elderly Prostate Cancer Patients with Low-grade Disease
Using genomic classifier scores, older men with low-risk prostate cancer were shown to harbor more aggressive disease than younger patients. This suggests that elderly patients…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer | NEJM
The comparative effectiveness of treatments for prostate cancer that is detected by prostate-specific antigen (PSA) testing remains uncertain. We compared active monitoring, radical prostatectomy, …
USPSTF Recommendation: Screening for Prostate Cancer
This 2018 updated Recommendation Statement from the US Preventive Services Task Force concludes that clinicians should not screen for prostate cancer in men aged 55…
Could GLP-1 RAs Lower Prostate Cancer Metastasis and Mortality Risks? – Renal and Urology News
Prior studies have suggested that GLP-1 RA use may decrease the incidence of prostate cancer.